minoxidil has been researched along with Dermatitis, Allergic Contact in 18 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
Dermatitis, Allergic Contact: A contact dermatitis due to allergic sensitization to various substances. These substances subsequently produce inflammatory reactions in the skin of those who have acquired hypersensitivity to them as a result of prior exposure.
Excerpt | Relevance | Reference |
---|---|---|
"Topical 2,4-diamino-6-piperidinopyrimidine-3-oxide (minoxidil) solution has been widely used for the treatment of androgenetic alopecia for over 15 years now and the substance is currently approved for this indication in 2% and 5% formulation." | 7.73 | Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution. ( Allam, JP; Bieber, T; Hagemann, T; Novak, N; Schlütter-Böhmer, B, 2005) |
"We report a 24-year-old woman with androgenetic alopecia who became sensitized to topical minoxidil following use of an extemporaneous preparation of minoxidil 4% with retinoic acid in a propylene glycol base." | 7.71 | Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia. ( Mallari, RS; Sinclair, RD; Tate, B, 2002) |
"After more than a decade of use, topical minoxidil solution has proven to be a safe and effective treatment for androgenetic alopecia." | 7.71 | Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. ( Cohen, DE; Friedman, ES; Friedman, PM; Washenik, K, 2002) |
"Topical 2,4-diamino-6-piperidinopyrimidine-3-oxide (minoxidil) solution has been widely used for the treatment of androgenetic alopecia for over 15 years now and the substance is currently approved for this indication in 2% and 5% formulation." | 3.73 | Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution. ( Allam, JP; Bieber, T; Hagemann, T; Novak, N; Schlütter-Böhmer, B, 2005) |
"We report a 24-year-old woman with androgenetic alopecia who became sensitized to topical minoxidil following use of an extemporaneous preparation of minoxidil 4% with retinoic acid in a propylene glycol base." | 3.71 | Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia. ( Mallari, RS; Sinclair, RD; Tate, B, 2002) |
"After more than a decade of use, topical minoxidil solution has proven to be a safe and effective treatment for androgenetic alopecia." | 3.71 | Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. ( Cohen, DE; Friedman, ES; Friedman, PM; Washenik, K, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (16.67) | 18.2507 |
2000's | 7 (38.89) | 29.6817 |
2010's | 4 (22.22) | 24.3611 |
2020's | 4 (22.22) | 2.80 |
Authors | Studies |
---|---|
Feryel, A | 1 |
Mouna, K | 1 |
Nesrine, BS | 1 |
Hichem, B | 1 |
Jameleddine, Z | 1 |
Navarro-Triviño, FJ | 1 |
Pegalajar-García, MD | 1 |
Gil-Villalba, A | 1 |
Ruiz-Villaverde, R | 1 |
Starace, M | 1 |
Bruni, F | 1 |
Marcondes, MT | 1 |
Alessandrini, A | 1 |
Piraccini, BM | 1 |
Nagarajan, H | 1 |
Rai, R | 1 |
Napolitano, M | 1 |
Cantelli, M | 1 |
Vastarella, M | 1 |
Nappa, P | 1 |
Fabbrocini, G | 1 |
Patruno, C | 1 |
García-Rodiño, S | 1 |
Espasandín-Arias, M | 1 |
Suárez-Peñaranda, JM | 1 |
Rodríguez-Granados, MT | 1 |
Vázquez-Veiga, H | 1 |
Fernández-Redondo, V | 1 |
Schmutz, JL | 1 |
Perera, E | 1 |
Yip, L | 1 |
Sinclair, R | 1 |
Sinclair, RD | 1 |
Mallari, RS | 1 |
Tate, B | 1 |
Hagemann, T | 1 |
Schlütter-Böhmer, B | 1 |
Allam, JP | 1 |
Bieber, T | 1 |
Novak, N | 1 |
Rodríguez-Martín, M | 1 |
Sáez-Rodríguez, M | 1 |
Carnerero-Rodríguez, A | 1 |
Cabrera de Paz, R | 1 |
Sidro-Sarto, M | 1 |
Pérez-Robayna, N | 1 |
Guimerá, F | 1 |
Sánchez, R | 1 |
García-Bustínduy, M | 1 |
Noda-Cabrera, A | 1 |
Ebner, H | 1 |
Müller, E | 1 |
Kimura, T | 1 |
Sánchez-Motilla, JM | 1 |
Pont, V | 1 |
Nagore, E | 1 |
Rodríguez-Serna, M | 1 |
Sánchez, JL | 1 |
Aliaga, A | 1 |
Scheman, AJ | 1 |
West, DP | 1 |
Hordinksy, MK | 1 |
Osburn, AH | 1 |
West, LE | 1 |
Friedman, ES | 1 |
Friedman, PM | 1 |
Cohen, DE | 1 |
Washenik, K | 1 |
Suzuki, K | 1 |
Suzuki, M | 1 |
Akamatsu, H | 1 |
Matsungaga, K | 1 |
Trattner, A | 1 |
David, M | 1 |
2 reviews available for minoxidil and Dermatitis, Allergic Contact
Article | Year |
---|---|
Alopecia areata.
Topics: Administration, Topical; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Autoimmunity; Cyclopro | 2015 |
Studies on development of hairless descendants of Mexican hairless dogs and their usefulness in dermatological science.
Topics: Animals; Blood Cell Count; Breeding; Dermatitis, Allergic Contact; Dermatology; Dihydroxyphenylalani | 1996 |
16 other studies available for minoxidil and Dermatitis, Allergic Contact
Article | Year |
---|---|
Unusual clinical presentation of allergic contact dermatitis to topical minoxidil.
Topics: Administration, Topical; Alopecia; Dermatitis, Allergic Contact; Humans; Minoxidil; Patch Tests | 2022 |
Allergic Contact Dermatitis Due to Minoxidil in a Patient with Alopecia Areata.
Topics: Administration, Topical; Alopecia; Alopecia Areata; Dermatitis, Allergic Contact; Humans; Minoxidil; | 2022 |
The identification of trichoscopic features of allergic scalp contact dermatitis: a pilot-study of a single center.
Topics: Allergens; Dermatitis, Allergic Contact; Humans; Minoxidil; Pilot Projects; Retrospective Studies; S | 2023 |
Contact dermatitis to minoxidil.
Topics: Adult; Alopecia; Dermatitis, Allergic Contact; Dermatologic Agents; Humans; Male; Minoxidil; Patch T | 2021 |
Allergic contact dermatitis probably caused by latanoprost during treatment for alopecia areata.
Topics: Administration, Cutaneous; Alopecia Areata; Dermatitis, Allergic Contact; Facial Dermatoses; Female; | 2019 |
Persisting allergic patch test reaction to minoxidil manifested as cutaneous lymphoid hyperplasia.
Topics: Dermatitis, Allergic Contact; Facial Dermatoses; Female; Humans; Middle Aged; Minoxidil; Patch Tests | 2015 |
[Persistent reaction to minoxidil skin patch testing mimicking pseudolymphoma].
Topics: Dermatitis, Allergic Contact; Dermatologic Agents; Diagnosis, Differential; Face; Female; Humans; Mi | 2015 |
Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia.
Topics: Administration, Topical; Adult; Alopecia; Dermatitis, Allergic Contact; Female; Humans; Minoxidil; P | 2002 |
Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution.
Topics: Administration, Topical; Aged; Alopecia; Dermatitis, Allergic Contact; Drug Eruptions; Female; Human | 2005 |
Pustular allergic contact dermatitis from topical minoxidil 5%.
Topics: Adult; Dermatitis, Allergic Contact; Drug Eruptions; Forehead; Humans; Male; Minoxidil; Scalp; Vasod | 2007 |
Allergic contact dermatitis from minoxidil.
Topics: Administration, Topical; Adult; Alopecia; Dermatitis, Allergic Contact; Drug Eruptions; Humans; Male | 1995 |
Pustular allergic contact dermatitis from minoxidil.
Topics: Adult; Alopecia; Dermatitis, Allergic Contact; Facial Dermatoses; Female; Humans; Minoxidil; Skin | 1998 |
Alternative formulation for patients with contact reactions to topical 2% and 5% minoxidil vehicle ingredients.
Topics: Administration, Topical; Alopecia; Chemistry, Pharmaceutical; Dermatitis, Allergic Contact; Dose-Res | 2000 |
Allergic contact dermatitis to topical minoxidil solution: etiology and treatment.
Topics: Administration, Topical; Aged; Alopecia; Dermatitis, Allergic Contact; Drug Eruptions; Female; Follo | 2002 |
Allergic contact dermatitis from minoxidil: study of the cross-reaction to minoxidil.
Topics: Cross Reactions; Dermatitis, Allergic Contact; Diagnosis, Differential; Hair Preparations; Humans; M | 2002 |
Pigmented contact dermatitis from topical minoxidil 5%.
Topics: Administration, Topical; Alopecia; Dermatitis, Allergic Contact; Humans; Hyperpigmentation; Male; Mi | 2002 |